Conference abstractPublished 2 Nov 2015
Identification and validation of the potential biomarkers Insulin-like growth factor-binding protein acid labile subunit and Vitamin D for breast cancer using Shot gun LC/MS and Western blot analysis
Loma Linda University School of Public Health, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Breast cancer is the most frequently diagnosed cancer in women, with an estimated 43,909 breast cancer deaths in the US and 70, 218 in India for the year 2012. While a majority of breast cancer patients in the US are postmenopausal, more than 80% of Indian patients are younger than 60 years of age, presenting with larger tumor size, poor tumor grade, and low rates of hormone-receptor positive status much like the triple negative breast cancer among African American women who participated in the current study. Because of the aggrssive nature of these tumors and current lack of targeted theapies, identification of novel relevant protein markers is of great improtance. The purpose of this study was to validate serum proteins that were identified by serum proteomic profiling in 22 serum samples by 2D-DIGE/MS analysis and a subset of samples by shotgun LC/MS technology. This study included 15 African American breast cancer patients and 12 healthy controls. Patients were grouped into triple negative (TN), HER2 and Luminal A and B subtypes. Proteins of biological significance were validated using western blot analysis. For ceruloplasmin, and Insulin-like growth factor-binding protein acid labile subunit (IGFBP-ALS), one-way ANOVA was used to compare mean density among the three groups. For Vitamin D Binding protein (VDB), a two-sample t-test was used to compare the density between the groups. Due to the small sample size, we have also conducted nonparametric tests. IGFBP-ALS was significantly higher in triple negative breast cancer patients (p=0.016) and in HER2 (p=0.025) subtypes. There was no significant difference in VDB protein in the luminal A and B subtypes (p=0.98). Future efforts will focus on validating the identified panel of biomarkers to gain insight into their role(s) in the etiology of aggressive breast tumors in the Indian population. Funded by Susan G Komen for the Cure and SEED grant SPH.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectDiabetes & Endocrinology
- SubjectNutrition & Food Science
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Padma P. Tadi Uppala”